अApnaFunda

SANOFI CONSUMER HEALTHCARE IND (SANOFICONR)

Consumer Non-Durables · Household/Personal Care · figures to Nov '26

Quality scoreHow the business itself ranks against its sector peers on profitability, 3-year growth and leverage. 50 is the middle of the sector.99 / 100
Profitability 98Balance sheet 100
Momentum scoreHow strong the recent trend is: 3-month price change, 12-month improvement in earnings and the rise in FII + DII holding, among companies above ₹500 cr.51 / 100
Price 8Earnings 79FII/DII 66

Passes these screensBusiness ahead of price

Share price

Closing priceAdjusted for splits and bonus issues.

₹3,449.3 latest close · −25.4% over the last 90 sessions

₹3,500₹4,000₹4,500Jul 3Jul 29Aug 24Sep 17Oct 14Nov 9 ₹3,500₹4,000₹4,500Jul 3Sep 4Nov 9

₹3,449.3 month-end · −26.0% over 12 months

₹3,500₹4,000₹4,500Nov '25Jan '26Apr '26Jun '26Sep '26Nov '26 ₹3,500₹4,000₹4,500Nov '25May '26Nov '26

₹3,449.3 month-end · −31.6% since Sep '24

₹4,000₹5,000Sep '24Feb '25Jul '25Jan '26Jun '26Nov '26 ₹4,000₹5,000Sep '24Oct '25Nov '26

52-week range ₹3168.20 to ₹5255.00 · 1-year volatility 30.9%

Was the rally earned?

-26%share price, 1 yearLower P/E held it back

Earnings helped, the multiple did not.

  • Per-share earnings added 25 points, but investors now pay less per rupee of profit (P/E 53.7x to 29.9x), which took 51 points back.
  • The share count barely moved.
Net profit growth: +25 pts. Points of the price return explained by net profit growing (or shrinking).+25 ptsNet profit growthP/E change: −51 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−51 ptsP/E changeShare price: −26%−26%Share priceNet profit growth: +25 pts. Points of the price return explained by net profit growing (or shrinking).+25ProfitP/E change: −51 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−51P/EShare price: −26%−26%Share price
Net profit growth+25 ptsNet profit rose about 33%, which lifts the price.
P/E change-51 ptsThe P/E fell from 53.7x to 29.9x, which lowers the price.
Share count change0 ptsShare count was little changed. More shares would count against the price.
What do "pts" mean?

"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.

Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.

Not shown for 3 years and 5 years: earnings were negative at one end, or there is not enough history.

Net profit is trailing twelve months as reported with a 60-day lag.

Compare this with HINDUSTAN UNILEVER

How rough has the ride been?

Maximum drawdown-43.7%not yet recovered
1-year volatility30.9%annualised
Beta vs sector index0.343-year daily, correlation 0.16
Volume spikes8last 90 sessions, 5x the 50-day median

Drawdown from peak

0%−20%−40%20252026−43.7% 0%−20%−40%20252026−43.7%
Largest drawdowns

-43.7% (2025-06 peak to 2026-10 low, not yet recovered)

Most recent volume spikes

2026-10-30: 12.8x the 50-day median, price -0.7% that day

2026-10-29: 125.5x the 50-day median, price +4.4% that day

2026-10-26: 5.4x the 50-day median, price +1.3% that day

Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).

Where does it rank among Consumer Non-Durables peers?

Each cell is the company's percentile rank among its Consumer Non-Durables peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

Where it ranks today

  • ROCE98thflat vs a year ago
  • Op. margin98thflat vs a year ago
  • Revenue growth84th▲ 77 pts vs a year ago
  • EPS growth76th
  • Debt/equity ↓81stflat vs a year ago
  • Cash cycle ↓95thflat vs a year ago
  • P/E ↓47th▲ 15 pts vs a year ago
  • 12M momentum32nd▼ 31 pts vs a year ago

Rank history

ROCE
Op. margin
Revenue growth
EPS growth
Debt/equity ↓
Cash cycle ↓
P/E ↓
12M momentum
Dec '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '26Nov '26
Lower rank Higher rank Not enough data

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Consumer Non-Durables sector page Watch it move against Consumer Non-Durables in the Observatory

What is the price implying?

~18%annual earnings growth implied by the price

At a P/E of 29.9x, the price would imply about 17.8%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.

Fewer than six years of annual earnings are available, which is too little to measure delivered growth.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect.

What prices imply across Consumer Non-Durables The market-wide Expectations lists

Key figures

Share Priceclose 9 Nov
₹3449.30
P/E
29.9x
Market Cap
₹7945 cr
Revenue (TTM)
₹950 cr
P/S
8.4x
P/B
22.8x
ROE
76.4%
Operating Margin
38.0%
Debt / Equity
0.1x
Promoter Holding
71.3%
12M Momentum
-26.0%

52-week range

₹3168.20₹5255.00
13% of the way from its 52-week low to its high

Price risk

1Y volatility
30.9%
Beta vs sector
1-year daily
0.44

Balance sheet & cash

Interest cover
operating profit ÷ interest
100.0x
Share count, 1Y
unchanged

Are profits backed by cash?

4 of 5checks within range1 near a threshold
Other income reliance6%Within range

Other income as a share of pre-tax profit (trailing twelve months): 5.6%. Bands: below 15%, 15% to 35%, above 35%.

Tax rate25%Within range

Median quarterly effective tax rate over about 2.5 years: 25.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.

Cash conversion1.05xWithin range

Operating cash flow divided by net profit over the last three fiscal years: 1.05x (cash from operations ₹614 cr, net profit ₹586 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.

Free cash flow2 of 3 yrsNear threshold

Fiscal years with positive free cash flow in the last 3: 2. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history—Not enough data

Not enough reported data to compute this.

Capital work in progress0% of fixed assetsWithin range

Capital work-in-progress is 0% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days—Not enough data

Not enough reported data to compute this.

Tap a check to see how it is measured

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

  • Over 2 years, promoters added 10.9 pts; DIIs trimmed 4.8 pts; FIIs trimmed 3.4 pts.
  • The number of shareholders fell from 61,091 to 47,511 (-22%) between Jun 2024 and Jun 2026.

Holdings, Jun '26

How each group changed

GroupJun '24Jun '26Change
Promoters60.4%71.3%+10.9 pts
FIIs6.0%2.6%-3.4 pts
DIIs22.6%17.9%-4.8 pts
Public and others11.0%8.3%-2.7 pts

Number of shareholders

47,511shareholders-22% since Jun '24
48k52k57k61k Jun '24Dec '24Jun '25Dec '25Jun '26
Jun '24: 61,091
Sep '24: 58,582
Dec '24: 55,734
Mar '25: 51,859
Jun '25: 49,632
Sep '25: 48,808
Dec '25: 48,075
Mar '26: 48,418
Jun '26: 47,511
48k52k57k61k Jun '24Mar '25Dec '25Jun '26
Jun '24: 61,091
Sep '24: 58,582
Dec '24: 55,734
Mar '25: 51,859
Jun '25: 49,632
Sep '25: 48,808
Dec '25: 48,075
Mar '26: 48,418
Jun '26: 47,511

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

What happened next to similar setups

−3.9%typical 12-month return vs the marketNot meaningfully different from the base rate
  • We found 50 past situations where a non-financial company looked like SANOFI CONSUMER HEALTHCARE IND today on valuation, margins, debt, growth, price momentum, size and volatility.
  • Over the following 12 months the middle half of them returned −24% to +11% vs the market, against −7% for all non-financial companies in the same months.
  • The gap against the base rate (+3.3%, 80% range −7.4% to +8.6%) is within what chance and overlapping periods produce.

Where the 50 outcomes landed

−60%−40%−20%0%+20%+40%+60%+80%
MAPMYINDIA · Jun 2025: −54.1% vs market
TCIEXP · Jun 2023: −47.0% vs market
THYROCARE · Dec 2021: −46.1% vs market
IGL · Feb 2021: −41.3% vs market
ATUL · Feb 2023: −40.8% vs market
NATCOPHARM · Feb 2022: −37.5% vs market
VINATIORGA · Jun 2023: −28.9% vs market
CLEAN · Sep 2025: −28.1% vs market
WONDERLA · Sep 2024: −27.7% vs market
CELLO · Nov 2024: −27.4% vs market
ADVENZYMES · Oct 2021: −27.3% vs market
FDC · Mar 2021: −27.2% vs market
DHANUKA · Apr 2021: −24.9% vs market
GRINDWELL · Nov 2023: −22.4% vs market
EMAMILTD · Dec 2021: −21.0% vs market
INDIGOPNTS · Jan 2024: −18.8% vs market
IRCTC · Dec 2024: −17.6% vs market
IPCALAB · Feb 2022: −16.9% vs market
EIHOTEL · Feb 2025: −16.8% vs market
VGUARD · Jul 2021: −15.6% vs market
AIAENG · Feb 2024: −10.2% vs market
SCHAEFFLER · Dec 2023: −9.6% vs market
LATENTVIEW · Aug 2024: −6.8% vs market
ERIS · Apr 2022: −6.0% vs market
TTKPRESTIG · Jul 2021: −5.6% vs market
INGERRAND · Aug 2024: −2.2% vs market
CAPLIPOINT · Aug 2021: −0.5% vs market
INDIAMART · Jan 2025: +0.5% vs market
CAMS · Jul 2025: +1.1% vs market
TIMKEN · Aug 2025: +1.3% vs market
TIPSMUSIC · Aug 2025: +2.8% vs market
SAREGAMA · Aug 2024: +2.9% vs market
AJANTPHARM · Feb 2022: +4.0% vs market
ICRA · Jan 2024: +4.7% vs market
COHANCE · Sep 2022: +7.3% vs market
HAPPYFORGE · Dec 2024: +9.0% vs market
BAJAJCON · Mar 2020: +9.1% vs market
BALKRISIND · Feb 2022: +11.6% vs market
JBCHEPHARM · Oct 2021: +14.0% vs market
GLAXO · Jan 2025: +14.5% vs market
CRISIL · Aug 2024: +21.2% vs market
SUMICHEM · Oct 2021: +26.2% vs market
NAVINFLUOR · Oct 2021: +31.4% vs market
ABBOTINDIA · Apr 2022: +32.3% vs market
MANKIND · Jul 2024: +34.4% vs market
AFFLE · Apr 2024: +39.2% vs market
CARBORUNIV · Apr 2022: +42.4% vs market
CUMMINSIND · Oct 2023: +49.9% vs market
CARERATING · Sep 2024: +63.4% vs market
HINDCOPPER · Aug 2025: +112.2% vs market
Similar setups −3.9%All companies −7.2%← worse than the marketbetter than the market →

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 1 beyond the range shown, drawn at the edge

Similar setups' median
−3.9%
All companies' median
−7.2%
Beat the market
46% vs 42%

50 past situations · 50 companies · 30 months · 2020–2025

The closest matches

CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
THYROCARE
Health Services
Dec 2021 52x36% +21%−24% −46%
INDIAMART
Retail Trade
Jan 2025 29x24% −18%−35% +1%
CRISIL
Commercial Services
Aug 2024 50x41% +12%−15% +21%
INDIGOPNTS
Process Industries
Jan 2024 52x— +23%−10% −19%
VINATIORGA
Process Industries
Jun 2023 45x28% −8%−22% −29%
Show the other 3 matches
CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
HINDCOPPER
Non-Energy Minerals
Aug 2025 48x24% −31%−34% +112%
LATENTVIEW
Commercial Services
Aug 2024 63x15% +14%−14% −7%
JBCHEPHARM
Health Technology
Oct 2021 29x33% +66%−15% +14%
How reliable is this?

Matched on P/E, P/S, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: 12-month momentum, drawdown from 12-month high and P/E. Not used (unavailable for this company): ROCE. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to SANOFI CONSUMER HEALTHCARE IND. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-11-09. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

FeatureWeightNon-financialFinancial
P/E1yesyes
P/S1yes—
P/B1—yes
ROCE1yes—
operating margin1yes—
ROE1—yes
debt/equity0.75yes—
interest cover0.5yes—
revenue growth0.75yesyes
12-month momentum1yesyes
drawdown from 12-month high0.75yesyes
size0.75yesyes
volatility0.5yesyes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

  • One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
  • Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
  • Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
  • Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
  • Pools: non-financial: 98,395 company-months from 2019 companies; financial: 5,659 company-months from 108 companies. 2349 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

What else looks like this?

Companies with the most similar financial profile today, regardless of industry.

NESCONESCO
Producer Manufacturing
68%similar
revenuevolatility
Health Technology
63%similar
debt/equitypromoter holding
Consumer Services
58%similar
operating marginP/E
Commercial Services
57%similar
P/Eoperating margin
Producer Manufacturing
55%similar
volatilitymarket cap
Consumer Non-Durables
43%similar
market capP/E
Consumer Non-Durables
41%similar
volatilityrevenue
ORKLA INDIAORKLAINDIA
Consumer Non-Durables
41%similar
market capvolatility

Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.

What changed?

16 events since Nov '24

  1. OctPriceFell 44% from the Jun 2025 peak to the Oct 2026 low.
  2. OctPriceVolume reached 125.5x its 50-day median on 2026-10-29; price +4.4% that day.
  3. JulPriceVolume reached 26.0x its 50-day median on 2026-07-29; price +0.8% that day.
  4. JunPriceVolume reached 24.2x its 50-day median on 2026-06-15; price +2.2% that day.
  5. MarResultsRevenue (TTM) reached a new high of ₹879 cr.
  6. MarDividendStarted paying a dividend (payout 72% of profit).
  7. FebPriceVolume reached 427.2x its 50-day median on 2026-02-26; price +13.8% that day.
  8. OctPriceVolume reached 17.8x its 50-day median on 2025-10-28; price -0.0% that day.
Show 8 earlier events
  1. SepPromoterPromoter holding rose 10.9 pts to 71.3%.
  2. SepInstitutionsFII + DII holding fell 9.9 pts over 1 quarter to 20.1%.
  3. SepSharesShare count is up 200.0% over 12 months.
  4. AugPriceVolume reached 61.2x its 50-day median on 2025-08-05; price +10.4% that day.
  5. JunDividendDividend payout cut from 70% to 0% of profit.
  6. JunPriceVolume reached 27.5x its 50-day median on 2025-06-30; price +13.6% that day.
  7. MarPriceVolume reached 32.6x its 50-day median on 2025-03-21; price -1.7% that day.
  8. NovPriceVolume reached 7.0x its 50-day median on 2024-11-25; price -0.0% that day.

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Monthly history27 months · 2024-09 to 2026-11
MonthP/ERevenue (TTM)ROEROCEDebt / Equity
2026-1129.9x₹950 cr76.4%—0.1x
2026-1029.8x₹950 cr76.4%—0.1x
2026-0932.9x₹950 cr76.4%—0.1x
2026-0837.0x₹935 cr67.2%90.0%0.1x
2026-0741.2x₹935 cr67.2%90.0%0.1x
2026-0641.1x₹935 cr67.2%90.0%0.1x
2026-0544.0x₹879 cr62.5%90.0%0.1x
2026-0445.7x₹879 cr62.5%90.0%0.1x
2026-0341.2x₹879 cr62.5%90.0%0.1x
2026-0247.4x₹799 cr79.9%111.0%0.1x
2026-0144.9x₹799 cr79.9%111.0%0.1x
2025-1247.8x₹799 cr79.9%111.0%0.1x
2025-1153.7x₹725 cr73.3%111.0%0.1x
2025-1055.8x₹725 cr73.3%111.0%0.1x
2025-0954.4x₹725 cr73.3%111.0%0.1x
2025-0871.0x₹676 cr61.5%111.0%0.1x
2025-0767.2x₹676 cr61.5%111.0%0.1x
2025-0677.9x₹676 cr61.5%111.0%0.1x
2025-0567.0x₹725 cr66.3%111.0%0.1x
2025-0462.9x₹725 cr66.3%111.0%0.1x
2025-0361.4x₹725 cr66.3%111.0%0.1x
2025-02—₹779 cr98.6%—0.0x
2025-01—₹779 cr98.6%—0.0x
2024-12—₹779 cr98.6%—0.0x
2024-11—₹829 cr111.1%—0.0x
2024-10—₹829 cr111.1%—0.0x
2024-09—₹829 cr111.1%—0.0x

Methodology and data notes

Methodology

Methodology and data notes

All figures come from public exchange prices and screener.in financial statements. Quarterly and annual results are shown from 60 days after the period end, so a month never uses a result before it would plausibly have been published. Statements are the latest versions, which may include later restatements.

Sector medians, percentiles and indices use today's listed companies in the sector (survivorship bias). Prices are adjusted for splits and bonus issues; around a corporate action the fundamentals may lag the price by up to a month, and affected sections are hidden.

The return decomposition uses price = P/E × net profit ÷ share count. The reverse DCF uses a fixed 12% cost of equity, a 10-year horizon and a 15x terminal P/E, and is an illustration only. Events, flags and twins follow fixed rules and thresholds described next to each section.

Feedback